13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001892134-24-000003
Total Value
$2.37B
Positions
50
Other Managers
0
Confidential Omitted
No
Holdings (50)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 12,226,943 | $289.2M | 12.20% |
| 2 | KRYSTAL BIOTECH INC | KRYS | 988,460 | $175.9M | 7.42% |
| 3 | MIRUM PHARMACEUTICALS INC | MIRM | 6,495,392 | $163.2M | 6.88% |
| 4 | HILLEVAX INC | 43157M102 | 9,781,472 | $162.7M | 6.86% |
| 5 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 3,131,008 | $124.1M | 5.24% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $107.4M | 4.53% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 3,415,604 | $105.6M | 4.46% |
| 8 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,190,179 | $94.9M | 4.00% |
| 9 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,785,284 | $87.1M | 3.67% |
| 10 | VAXCYTE INC | PCVX | 1,139,405 | $77.8M | 3.28% |
| 11 | TARSUS PHARMACEUTICALS INC | TARS | 1,787,527 | $65.0M | 2.74% |
| 12 | EDGEWISE THERAPEUTICS INC | EWTX | 3,303,567 | $60.3M | 2.54% |
| 13 | ORIC PHARMACEUTICALS INC | ORIC | 4,142,855 | $57.0M | 2.40% |
| 14 | APELLIS PHARMACEUTICALS INC | APLS | 885,165 | $52.0M | 2.20% |
| 15 | DISC MEDICINE INC | IRON | 785,000 | $48.9M | 2.06% |
| 16 | VERONA PHARMA PLC | 925050106 | 3,014,349 | $48.5M | 2.05% |
| 17 | KALVISTA PHARMACEUTICALS INC | KALV | 3,687,867 | $43.7M | 1.85% |
| 18 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,561,230 | $42.1M | 1.77% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 875,667 | $37.5M | 1.58% |
| 20 | MACROGENICS INC | MGNX | 2,471,704 | $36.4M | 1.54% |
| 21 | AEROVATE THERAPEUTICS INC | 008064107 | 1,204,867 | $35.6M | 1.50% |
| 22 | CG ONCOLOGY INC | CGON | 770,000 | $33.8M | 1.43% |
| 23 | MERUS N V | N5749R100 | 746,479 | $33.6M | 1.42% |
| 24 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $32.1M | 1.36% |
| 25 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $29.5M | 1.24% |
| 26 | STRUCTURE THERAPEUTICS INC | GPCR | 629,194 | $27.0M | 1.14% |
| 27 | TREVI THERAPEUTICS INC | TRVI | 7,381,090 | $25.5M | 1.07% |
| 28 | SILENCE THERAPEUTICS PLC | SLNCF | 1,148,591 | $24.8M | 1.05% |
| 29 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 1,455,837 | $22.9M | 0.97% |
| 30 | PEPGEN INC | PEPG | 1,502,788 | $22.1M | 0.93% |
| 31 | ANAPTYSBIO INC | ANABV | 899,700 | $20.3M | 0.85% |
| 32 | SAVARA INC | SVRA | 4,000,000 | $19.9M | 0.84% |
| 33 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 393,000 | $16.6M | 0.70% |
| 34 | AGIOS PHARMACEUTICALS INC | AGIO | 523,166 | $15.3M | 0.65% |
| 35 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 1,069,244 | $15.1M | 0.64% |
| 36 | PUMA BIOTECHNOLOGY INC | PBYI | 2,816,294 | $14.9M | 0.63% |
| 37 | TYRA BIOSCIENCES INC | TYRA | 832,220 | $13.6M | 0.58% |
| 38 | APPLIED THERAPEUTICS INC | 03828A101 | 1,952,857 | $13.3M | 0.56% |
| 39 | ALLOGENE THERAPEUTICS INC | ALLO | 2,867,750 | $12.8M | 0.54% |
| 40 | ARVINAS INC | ARVN | 285,331 | $11.8M | 0.50% |
| 41 | 89BIO INC | 282559103 | 1,000,000 | $11.6M | 0.49% |
| 42 | ACADIA PHARMACEUTICALS INC | ACAD | 470,338 | $8.7M | 0.37% |
| 43 | COGENT BIOSCIENCES INC | COGT | 936,576 | $6.3M | 0.27% |
| 44 | INTELLIA THERAPEUTICS INC | NTLA | 203,684 | $5.6M | 0.24% |
| 45 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $5.5M | 0.23% |
| 46 | AN2 THERAPEUTICS INC | ANTX | 1,388,889 | $4.5M | 0.19% |
| 47 | METAGENOMI INC | MGX | 279,025 | $2.9M | 0.12% |
| 48 | GRITSTONE BIO INC | 39868T105 | 1,030,878 | $2.6M | 0.11% |
| 49 | BLUEBIRD BIO INC | 09609G100 | 1,709,907 | $2.2M | 0.09% |
| 50 | ACLARIS THERAPEUTICS INC | ACRS | 264,377 | $327,827 | 0.01% |